USFDA broadens indication for Eli Lilly's Verzenio in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer Ruchika Sharma5 March 2023 11:00 AM GMTVerzenio (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Eli Lilly unveils DCGI approved Ramiven in India for early stage breast cancer Ruchika Sharma24 Nov 2022 10:30 AM GMTRamiven (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
FDA approves new Drug for Early Breast Cancer Dr. Kamal Kant Kohli14 Oct 2021 2:09 PM GMTThe US food and drug administration has approved a new drug abemaciclib for one type of breast cancer. FDA has s approved Abemaciclib in...
Eli Lilly gets USFDA nod to Verzenio as adjuvant therapy for breast cancer patients Ruchika Sharma14 Oct 2021 6:30 AM GMTIndianapolis: Eli Lilly and Company has recently announced that the U.S.Food and Drug Administration (USFDA) has approved the...
